Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 4(6): e5853, 2009 Jun 10.
Article in English | MEDLINE | ID: mdl-19516896

ABSTRACT

BACKGROUND: A hallmark of AIDS progression is a switch of cytokines from Th1 to Th2 in the plasma of patients. IL-12, a critical Th1 cytokine secreted by antigen presenting cells (APCs) is suppressed by Vpr, implicating it as an important virulence factor. We hypothesize that Vpr protein packaged in the virion may be required for disabling APCs of the first infected mucosal tissues. Consistent with this idea are reports that defects in the C-terminus of Vpr are associated with long-term non-progression. PRINCIPAL FINDINGS: Vpr RNA amplified from various sources was electroporated into monocyte-derived DC and IL-12 levels in supernatants were analyzed. The analysis of previously reported C-terminal Vpr mutations demonstrate that they do not alleviate the block of IL-12 secretion. However, a novel single conservative amino acid substitution, R90K, reverses the IL-12 suppression. Analysis of 1226 Vpr protein sequences demonstrated arginine (R) present at position 90 in 98.8%, with other substitutions at low frequency. Furthermore, none of sequences report lysine (K) in position 90. Vpr clones harboring the reported substitutions in position 90 were studied for their ability to suppress IL-12. Our data demonstrates that none of tested substitutions other than K relieve IL-12 suppression. This suggests a natural selection for sequences which suppress IL-12 secretion by DC and against mutations which relieve such suppression. Further analyses demonstrated that the R90K, as well as deletion of the C-terminus, directs the Vpr protein for rapid degradation. CONCLUSION: This study supports Vpr as an HIV virulence factor during HIV infection and for the first time provides a link between evolutionary conservation of Vpr and its ability to suppress IL-12 secretion by DC. DC activated in the presence of Vpr would be defective in the production of IL-12, thus contributing to the prevailing Th2 cytokine profile associated with progressive HIV disease. These findings should be considered in the design of future immunotherapies that incorporate Vpr as an antigen.


Subject(s)
Gene Products, vpr/metabolism , HIV Infections/metabolism , Immunosuppressive Agents/pharmacology , Interleukin-12/metabolism , Mucous Membrane/virology , vpr Gene Products, Human Immunodeficiency Virus/chemistry , vpr Gene Products, Human Immunodeficiency Virus/metabolism , Dendritic Cells/metabolism , Humans , Mucous Membrane/metabolism , Mutation , Plasmids/metabolism , Protein Structure, Tertiary , RNA, Viral/metabolism , Transcription, Genetic , Ubiquitin/metabolism , Virulence Factors
2.
J Virol Methods ; 156(1-2): 138-44, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19095009

ABSTRACT

This study was performed to demonstrate that RNA isolated from cell lines and cervical cytology specimens stored in SurePath preservative fluid would be functional in real-time RT-PCR assays. RNA was isolated from cervical cell lines or cytology samples stored in SurePath preservative at room temperature for 2-5 weeks using five commercially available RNA purification kits, three of which contain proteinases. The quality of the RNA was assessed by real time RT-PCR amplification of GAPDH, GUSB, U1A, HPV 16 and 18 E6 mRNAs. RNA was isolated successfully from cells that were stored in SurePath preservative fluid with only the three protocols that contained proteinases. GAPDH was amplified in 98-100% of the samples, GUSB in 90-98%, and the least abundant transcript, U1A, was amplified in 81-96% of the samples. HPV 16 and 18 E6 transcripts were detected in 56% of high grade, 39% of low grade and 2% of normal samples, with a concordance between DNA genotype and E6 mRNA expression of 97%. We demonstrated that RNA can be extracted from cervical cell lines and cytology specimens stored in BD SurePath preservative fluid with three different procedures that all contain proteinases. This RNA is suitable for real-time RT-PCR applications.


Subject(s)
Cervix Uteri/virology , Genes, Viral/genetics , Human papillomavirus 16/genetics , Human papillomavirus 18/genetics , RNA, Viral/isolation & purification , DNA-Binding Proteins/genetics , Female , Genotype , HeLa Cells , Humans , Oncogene Proteins, Viral/genetics , Preservation, Biological , RNA, Viral/analysis , Random Allocation , Reagent Kits, Diagnostic , Repressor Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Vaginal Smears
3.
BMC Mol Biol ; 9: 90, 2008 Oct 17.
Article in English | MEDLINE | ID: mdl-18928538

ABSTRACT

BACKGROUND: RNA transfection into dendritic cells (DCs) is widely used to achieve antigen expression as well as to modify DC properties. CD40L is expressed by activated T cells and interacts with CD40 receptors expressed on the surface of the DCs leading to Th1 polarization. Previous studies demonstrated that ectopic CD40L expression via DNA transfection into DCs can activate the CD40 receptor signal transduction cascade. In contrast to previous reports, this study demonstrates that the same effect can be achieved when RNA encoding CD40L is electroporated into DCs as evidenced by secretion of IL-12. To achieve higher levels of IL-12 secretion, a systematic approach involving modification of coding and noncoding regions was implemented to optimize protein expression in the DCs for the purpose of increasing IL-12 secretion. RESULTS: Site-directed mutagenesis of each of the first five in-frame methionine codons in the CD40L coding sequence demonstrated that DCs expressing a truncated CD40L protein initiated from the second methionine codon secreted the highest levels of IL-12. In addition, a post-transcriptional method of capping was utilized for final modification of the CD40L RNA. This method enzymatically creates a type I cap structure identical to that found in most eukaryotic mRNAs, in contrast to the type 0 cap incorporated using the conventional co-transcriptional capping reaction. CONCLUSION: The combination of knocking out the first initiation methionine and post-transcriptional capping of the CD40L RNA allowed for approximately a one log increase in IL-12 levels by the transfected DCs. We believe this is a first report describing improved protein expression of post-transcriptionally capped RNA in DCs. The post-transcriptional capping which allows generation of a type I cap may have broad utility for optimization of protein expression from RNA in DCs and other cell types.


Subject(s)
CD40 Ligand/genetics , Dendritic Cells/metabolism , Interleukin-12/biosynthesis , RNA Processing, Post-Transcriptional , 5' Untranslated Regions/chemistry , Amino Acid Sequence , Base Sequence , CD40 Antigens/physiology , CD40 Ligand/biosynthesis , Cells, Cultured , Codon, Initiator/genetics , Molecular Sequence Data , Mutagenesis, Site-Directed , RNA Caps/metabolism , Up-Regulation
4.
J Virol Methods ; 154(1-2): 220-2, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18761379

ABSTRACT

Infection with high-risk human papillomavirus (HPV) is known to be associated directly with the development of cervical cancer. Recent data suggests that the detection of E6/E7 mRNA from high-risk HPV types may serve as a better diagnostic method for detecting the presence of cervical pre-cancer than HPV DNA testing. This report details a commercially available nucleic acid isolation protocol which can be used to isolate reproducibly RNA from residual BD SurePath liquid-based cytology specimens stored for up to 28 days, and have demonstrated the quality and quantity of mRNA is sufficient for detection with the NorChip PreTect HPV-Proofer assay. Of the 242 specimens tested in this study, 236 (97.5%) tested positive for U1A internal control gene expression. HPV type 16, 18, 31, 33 or 45 mRNA was detected in 16/20 (80%) of the analyzed high-grade squamous intraepithelial lesion (HSIL) specimens, with a low frequency of HPV mRNA detected in the normal lesions (3%). The presence of HPV E6 expression in a subset of HPV positive specimens was also detected by real-time RT-PCR. These findings confirm that RNA of sufficient quality can be isolated from residual BD SurePath cervical cytology specimens for use in downstream NASBA and RT-PCR-based assays.


Subject(s)
Oncogene Proteins, Viral/genetics , Papillomaviridae/genetics , Papillomavirus Infections/diagnosis , RNA, Messenger/isolation & purification , RNA, Viral/isolation & purification , Female , Humans , Specimen Handling/methods , Vaginal Smears
5.
Proc Natl Acad Sci U S A ; 101(44): 15694-9, 2004 Nov 02.
Article in English | MEDLINE | ID: mdl-15501916

ABSTRACT

Bloom syndrome is a rare disorder associated with cancer predisposition and genomic instability and is caused by loss of the RecQ helicase BLM. The Drosophila ortholog of BLM (DmBlm) is required for accurate repair of DNA double-strand gaps by homologous recombination. Repair products from DmBlm mutants have shorter repair synthesis tract lengths compared to wild type and are frequently associated with deletions flanking the break site. To determine the mechanisms responsible for deletion formation in the absence of DmBlm, we characterized repair after excision of the P[w(a)] element in various genetic backgrounds. Flies lacking DmRad51 do not have an elevated deletion frequency. Moreover, loss of DmRad51 suppresses deletion formation in DmBlm mutants. These data support a model in which DmBlm acts downstream of strand invasion to unwind a D-loop intermediate to free the newly synthesized strand. In the absence of DmBlm, alternative pathways of D-loop disassembly result in short repair synthesis tracts or flanking deletions. This model explains how RecQ helicases can promote homologous recombination while preventing illegitimate recombination.


Subject(s)
DNA Helicases/genetics , DNA Repair/genetics , Drosophila/genetics , Genes, Insect , Animals , Animals, Genetically Modified , Chromosome Breakage , DNA/biosynthesis , DNA/genetics , Drosophila Proteins , Female , Male , Models, Genetic , Mutation , Sequence Deletion
6.
Science ; 299(5604): 265-7, 2003 Jan 10.
Article in English | MEDLINE | ID: mdl-12522255

ABSTRACT

Bloom syndrome, characterized by a predisposition to cancer, is caused by mutation of the RecQ DNA helicase gene BLM. The precise function of BLM remains unclear. Previous research suggested that Drosophila BLM functions in the repair of DNA double-strand breaks. Most double-strand breaks in flies are repaired by homologous recombination through the synthesis-dependent strand-annealing pathway. Here, we demonstrate that Drosophila BLM mutants are severely impaired in their ability to carry out repair DNA synthesis during synthesis-dependent strand annealing. Consequently, repair in the mutants is completed by error-prone pathways that create large deletions. These results suggest a model in which BLM maintains genomic stability by promoting efficient repair DNA synthesis and thereby prevents double-strand break repair by less precise pathways.


Subject(s)
DNA Damage , DNA Helicases/physiology , DNA Repair , DNA/biosynthesis , Drosophila Proteins/physiology , Drosophila/metabolism , Animals , DNA/metabolism , DNA Helicases/genetics , Drosophila/genetics , Drosophila Proteins/genetics , Eye Color , Female , Genes, Insect , Male , Mutation , Terminal Repeat Sequences , Transposases/metabolism
7.
Nat Rev Genet ; 3(3): 189-98, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11972156

ABSTRACT

There has been a long history of innovation and development of tools for gene discovery and genetic analysis in Drosophila melanogaster. This includes methods to induce mutations and to screen for those mutations that disrupt specific processes, methods to map mutations genetically and physically, and methods to clone and characterize genes at the molecular level. Modern genetics also requires techniques to do the reverse to disrupt the functions of specific genes, the sequences of which are already known. This is the process referred to as reverse genetics. During recent years, some valuable new methods for conducting reverse genetics in Drosophila have been developed.


Subject(s)
Drosophila melanogaster/genetics , Animals , DNA Repair , Gene Expression , Gene Targeting , Genes, Insect , Genetic Testing , Models, Genetic , Mutagenesis, Insertional , Phenotype , Recombination, Genetic
8.
Genes Dev ; 16(1): 72-84, 2002 Jan 01.
Article in English | MEDLINE | ID: mdl-11782446

ABSTRACT

Direct interactions between RNA-binding proteins and snRNP particles modulate eukaryotic pre-mRNA processing patterns to control gene expression. Here, we report that the conserved U1 snRNP-interacting RNA-binding protein PSI is essential for Drosophila viability. A null PSI mutation is recessive lethal at the first-instar larval stage, and lethality is fully rescued by transgenes expressing the PSI protein. A mutant transgene that lacks the PSI-U1 snRNP-interaction domain restores viability but shows courtship behavior abnormalities and meiosis defects during spermatogenesis, resulting in a complete male sterility phenotype. Using cDNA microarrays, we have identified specific target mRNAs with altered expression profiles in these mutant males. A subset of these transcripts is also found associated with PSI in endogenous immunopurified ribonucleoprotein complexes. One specific target, the hrp40/squid transcript, shows an altered pre-mRNA splicing pattern in PSI mutant testes. We conclude that a functional association between the PSI protein and the spliceosomal U1 snRNP particle is required for normal Drosophila development and for the processing of specific PSI-interacting cellular transcripts. These results also validate the use of cDNA microarrays to characterize in vivo RNA-processing defects and alternative pre-mRNA splicing patterns.


Subject(s)
Drosophila Proteins , Drosophila melanogaster/physiology , Nuclear Proteins , RNA Precursors , RNA, Messenger , RNA-Binding Proteins/physiology , Animals , Fertility/genetics , Gene Expression Regulation/physiology , Male , RNA Precursors/genetics , RNA Precursors/metabolism , RNA Processing, Post-Transcriptional , RNA Splicing , RNA, Messenger/genetics , RNA, Messenger/metabolism , Ribonucleoproteins, Small Nuclear/physiology , Spermatogenesis/genetics
9.
Genetics ; 162(4): 1557-71, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12524332

ABSTRACT

Spt16/Cdc68, Pob3, and Nhp6 collaborate in vitro and in vivo as the yeast factor SPN, which is homologous to human FACT. SPN/FACT complexes mediate passage of polymerases through nucleosomes and are important for both transcription and replication. An spt16 mutation was found to be intolerable when combined with a mutation in any member of the set of functionally related genes HIR1, HIR2/SPT1, HIR3/HPC1, or HPC2. Mutations in POB3, but not in NHP6A/B, also display strong synthetic defects with hir/hpc mutations. A screen for other mutations that cause dependence on HIR/HPC genes revealed genes encoding members of the Paf1 complex, which also promotes transcriptional elongation. The Hir/Hpc proteins affect the expression of histone genes and also promote normal deposition of nucleosomes; either role could explain an interaction with elongation factors. We show that both spt16 and pob3 mutants respond to changes in histone gene numbers, but in opposite ways, suggesting that Spt16 and Pob3 each interact with histones but perhaps with different subsets of these proteins. Supporting this, spt16 and pob3 mutants also display different sensitivities to mutations in the N-terminal tails of histones H3 and H4 and to mutations in enzymes that modulate acetylation of these tails. Our results support a model in which SPN/FACT has two functions: it disrupts nucleosomes to allow polymerases to access DNA, and it reassembles the nucleosomes afterward. Mutations that impair the reassembly activity cause chromatin to accumulate in an abnormally disrupted state, imposing a requirement for a nucleosome reassembly function that we propose is provided by Hir/Hpc proteins.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Chromatin/metabolism , Chromosomal Proteins, Non-Histone , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Acetyltransferases/genetics , Acetyltransferases/metabolism , Chromatin Assembly Factor-1 , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Dosage , Genes, Fungal , HMGN Proteins , Histone Acetyltransferases , Histones/chemistry , Histones/genetics , Histones/metabolism , Models, Biological , Mutation , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Phenotype , Repressor Proteins/genetics , Repressor Proteins/metabolism , Saccharomyces cerevisiae Proteins/genetics , Trans-Activators/genetics , Trans-Activators/metabolism , Transcriptional Activation , Transcriptional Elongation Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...